INIS
patients
100%
liver
74%
hepatitis
51%
diseases
45%
viruses
35%
hepatomas
34%
indonesia
33%
liver cirrhosis
22%
therapy
19%
fibrosis
19%
risks
17%
management
17%
levels
16%
hospitals
14%
values
11%
cancer
11%
hypertension
10%
genotype
10%
esophagus
10%
recommendations
9%
guidelines
9%
hiv
9%
comparative evaluations
9%
mortality
8%
correlations
8%
failures
7%
humans
7%
screening
7%
children
6%
evaluation
5%
covid-19
5%
data
5%
drugs
5%
veins
5%
sensitivity
5%
pancreas
5%
mutations
5%
proteins
5%
Keyphrases
Indonesia
35%
Hepatocellular Carcinoma
33%
Liver Cirrhosis
22%
Hepatitis C Virus
15%
Non-alcoholic Fatty Liver Disease (NAFLD)
13%
Endoscopic Ultrasound
13%
Transient Elastography
13%
APASL
10%
Antiretroviral Therapy
9%
Portal Hypertension
9%
Cirrhosis
9%
Hepatitis B Virus
8%
Hepatitis C
8%
Asian Pacific Association for the Study of the Liver
8%
Chronic Liver Disease
8%
Hepatitis C Virus Infection
8%
Hepatocellular Carcinoma Patients
8%
Liver Fibrosis
7%
Acute-on-chronic Liver Failure
7%
Liver Disease
7%
Esophageal Varices
7%
Alpha-fetoprotein
7%
Clinical Practice Guidelines
7%
COVID-19
6%
Jakarta
6%
Co-infected Patients
6%
Chronic Hepatitis C
6%
Consensus Recommendations
6%
Controlled Attenuation Parameter
6%
HIV-HCV
6%
Liver
5%
α1-acid Glycoprotein
5%
AIDS/HIV
5%
Chronic Hepatitis B Patients
5%
Medicine and Dentistry
Hepatocellular Carcinoma
31%
Liver Cirrhosis
23%
Endoscopic Ultrasound
14%
Portal Hypertension
11%
Nonalcoholic Fatty Liver
11%
Transient Elastography
10%
Esophageal Varices
10%
Fibrosis
10%
Hepatitis B
9%
Patient Referral
9%
Hepatitis C Virus
7%
Hepatitis B Virus
7%
Chronic Liver Disease
7%
Diagnosis
7%
COVID-19
7%
Liver Disease
6%
Liver Fibrosis
6%
Chronic Hepatitis B
6%
Human Immunodeficiency Virus
6%
Infection
6%
Hepatitis C
5%
Chronic Hepatitis C
5%
Retrospective Cohort Study
5%